---
title: "Tango Therapeutics (TNGX.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/TNGX.US/norm.md"
symbol: "TNGX.US"
name: "Tango Therapeutics"
parent: "https://longbridge.com/en/quote/TNGX.US.md"
datetime: "2026-05-20T19:27:36.201Z"
locales:
  - [en](https://longbridge.com/en/quote/TNGX.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/TNGX.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/TNGX.US/norm.md)
---

# Tango Therapeutics (TNGX.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.3170 | -0.2945 | 0.1300 | -0.3515 | -0.3615 |
| ROE | -49.36% | -61.24% | 43.08% | -103.02% | -87.10% |
| Revenue | - | 0.0000 | 53.81M | 3.18M | 5.39M |
| Net income | -45.51M | -38.75M | 15.88M | -38.85M | -39.88M |
| Operating income | -48.77M | -41.86M | 14.07M | -40.97M | -42.53M |
| Gross margin | - | - | 42.73% | -931.34% | -575.85% |
| Net margin | - | - | 29.52% | -1221.41% | -739.54% |
| Profit quality | - | - | -45.46% | - | - |

## Balance Sheet (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 435.79M | 398.69M | 210.14M | 237.89M | 274.31M |
| Leverage | 1.11 | 1.15 | 1.31 | 1.76 | 1.65 |
| BVPS | 2.72 | 2.55 | 1.43 | 1.22 | 1.54 |
| Turnover | 0.1605 | 0.1745 | 0.2364 | 0.0785 | 0.1205 |
| Cash & STI | 379.84M | 343.14M | 152.81M | 180.78M | 216.72M |
| Inv & Rec | - | - | - | - | - |
| LT assets | 41.03M | 42.49M | 43.93M | 45.34M | 47.24M |
| Net debt | -347.05M | -309.57M | -118.05M | -145.78M | -179.78M |

## Cash Flow Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -44.36M | -29.72M | -30.95M | -36.52M | -41.70M |
| Investing CF | 9.63M | -135.72M | 47.48M | 16.78M | 30.60M |
| Financing CF | 79.85M | 219.38M | 2.54M | 581000.00 | 2000.00 |
| Free CF | -28.53M | -15.98M | -7.98M | -15.74M | -21.16M |
| OCF coverage | - | -13386.49% | -20498.01% | -5852.40% | -81758.82% |
| Repaid & issued | - | - | - | - | - |
| CapEx | - | -222000.00 | -151000.00 | -624000.00 | -51000.00 |